“Medicinal marijuana is bad medicine” - CMA president
by Xavier Symons | 30 Aug 2014 |
tags: Canada, clinical trials, drugs, marijuana
The debate surrounding Canada’s marijuana laws has intensified, with the president of the Canadian Medical Association (CMA) labeling medicinal marijuana “bad medicine”.
Dr. Louis Hugo Francescutti is skeptical about the benefits of the controversial treatment. He voiced his concerns at the CMA’s annual meeting in Ottawa on the 18th of August: “It’s just plain bad medicine to prescribe a product when we don’t know how it works, we don’t know when it works, who it works for, how it interacts or how much to prescribe….”.
Under current Canadian law, patients wishing to purchase medicinal marijuana need to obtain a prescription from a doctor. Many doctors are unsure about the treatment and hence reluctant to issue a prescription.
Dr. Francescutti is concerned about the effect of current legislation on doctor-patient relations: “It puts physicians in a very awkward situation and it strains the physician-patient relationship”.
Debate about the legalization of marijuana has become a central issue in the run up to the expected 2015 Canada federal elections. The Liberal Party supports a change in the law on the grounds that it would make it easier to control the drug and take power out of the hands of organized crime.
No hay comentarios:
Publicar un comentario